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1. Introduction
Helicobacter pylori (H.pylori) may cause many gastroduodenal diseases including acute gastri‐
tis, atrophic gastritis, intestinal metaplasia, peptic ulcer and others disorders. Although
many studies revealed close association between gastric cancer and H.pylori, there have been
only few studies that report on gastric carcinogenesis associated with chronic H.pylori [1,2]
H.pylori is a class 1 gastric carcinogen. However, it remains unclear whether H.pylori affects
molecular alterations in chronic gastritis. It is well known that only a minority of H.pylori
positive patients with chronic gastritis develop gastric cancer, and so the link is unclear [2].
Nardone et al [3] had stated that gastric carcinogenesis is a multistep process progressing
from chronic gastritis through glandular atrophy, metaplasia, and dysplasia. Acquired ge‐
nomic instability, generally precedes neoplastic clonal expansion. H.pylori damages stimu‐
lates gastric cell proliferation, which leads to mucosal repair, but which can also induce
cellular DNA damage. The most frequent epiphenomenon of DNA alteration is activation of
oncogenes and/or mutation of oncosuppressor genes. The role of these genes has been stud‐
ied in gastric carcinogenesis, but their interrelation with H.pylori infection has yet to be de‐
fined. Thus, this study was designed to detect the relation between H.pylori and gastric
carcinogenesis and to investigate the effect of its eradication on the expression of p53 and c-
Myc in H.pylori associated chronic gastritis.
As a transcription factor, p53 has roles in regulation of proliferation, apoptosis, genomic re‐
pair, controls the onset of cellular senescence and suppresses angiogenesis [4,5]. p53 muta‐
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tion is among the major episodes in the multi-step process of gastric carcinogenesis, while it
has also been reported in pre-malignant lesions of the stomach, such as chronic atrophic gas‐
tritis, intestinal metaplasia, and dysplasia [1].
c-Myc is a basic transcriptional factor that regulates several genes involved in cell prolifera‐
tion, differentiation, apoptosis, and oncogenesis. c-Myc expression was studied in gastric
cancer with H.pylori infection by many authors [6,7]. Also the relationship between H.pylori
infection and c-Myc expressions was investigated in a series of diseases and concluded that
in gastric carcinogenesis, H.pylori might cause the imbalance of proliferation and apoptosis
in precancerous lesions, leading to tumor-suppressor system mutation and telomerase reac‐
tivation, and finally causes gastric cancer [8].
2. Material and methods
2.1. Patients and tissue collection
A total of 55 chronic gastritis patients (38 male and 17 female with mean age: 57.1) under‐
went endoscopic examination for evaluation of dyspypsia. H.pylori-positive (+) were 45 cas‐
es while H.pylori-negative (-) were only 10 cases. All H.pylori-positive patients had successful
eradication therapy (15 days of treatment with omeprazole 20 mg twice a day, clarithromy‐
cin 500 mg twice a day, and tinidazole 500 mg twice a day), and underwent biopsies before
and six months after eradication.
2.2. Detection of H. pylori in gastric biopsy specimens
H.pylori in the stomach was detected by rapid urease test, and histological examination. For
the urease test, biopsy specimens were immediately inserted into the rapid urease test solu‐
tion. H.pylori was histologically detected by May-Giemsa stain. H.pylori eradication was con‐
sidered successful when the results of the two tests (both the urase test and Giemsa stain)
were found negative.
2.3. Histological evaluation
Biopsy specimens were taken from five points of the stomach, as recommended by the up‐
dated Sydney system [9], i.e. the lesser curvature of the antrum, and the greater curvature of
the antrum, the smaller curvature of the angle, and the lesser curvature of the middle cor‐
pus, and the greater curvature of the upper corpus. All biopsy materials were fixed in buf‐
fered formalin for 24 hours and embedded in paraffin. Serial sections were stained with
haematoxylin-eosin and May-Giemsa stain. The status of the gastric mucosa was evaluated
according to the updated Sydney system. The degree of inflammation (manifested by mild
lymphocyte and plasma-cell infiltration), neutrophil activity, atrophy (glandular morpholo‐
gy absent in the mucosa and replaced by connective tissue, inter-glandular space was infil‐
trated by plasma cells and lymphocytes), dysplasia (nuclear atypia with or without
architectural abnormalities in the gastric epithelium, but without invasion) and intestinal
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metaplasia (presence of goblet cells in gastric mucosa) were classed by four grades, with 0
being for ‘normal’, 1 for ‘mild’, 2 for ‘moderate’, and 3 for ‘marked’.
2.4. Immunohistochemical detection of p53and c-Myc
Serial paraffin sections were washed in 1/15 mol/L phosphate buffered saline (pH 7.4) three
times for five minutes, and pre-incubated in normal rabbit serum (1:10 in PBS) for 20 min.
Next, sections were incubated with primary antibodies for 16 hours at 4C, followed by the
avidin-biotin complex method. The sections were immersed in 0.05 mol/L Tris-HCl buffer
containing 0.02% 3, 3’-diaminobenzidine tetrahydrochloride and 0.005% H2O2, and the nu‐
clei were counterstained with hematoxylin. Control sections incubated with normal mouse
IgG instead of the primary antibody showed no non-specific staining. The primary antibod‐
ies used in this study for p53, staining the sections were incubated with anti-rabbit or mouse
antibody (Envision HRP, Dako Company) for 10 min and anti-c-Myc protein (Oncogene Sci‐
ence, San Diego, California, USA; c-Myc p62, dilution 1:50) After antigen retrieval (for c-Myc
in 1mM EDTA (pH 8.0), sections were incubated overnight at 41C with monoclonal mouse
antibodies to c-Myc (1:100 dilution, Abcam Inc., Cambridge, MA, USA). Immunoreactivity
was detected using the DAB Map Kit (PIERCE, Woburn, MA, USA), based on the avidin–
biotin complex immunoperoxidase technique.
2.5. Evaluation of p53 and c-Myc staining
The degree of immunopositivity was evaluated semiquantitatively. A total of 300 cells was
counted in random fields from representative areas of the lesions, and the immunoreactive
cells were roughly assessed and expressed as percentages. The scoring system for both anti‐
bodies tested was: 0–5% (negative -); 5–25% (low positivity +); 25–50% (moderate positivity +
+); >50% (high positivity +++) according to Nardone et al [3].
2.6. Statistical analysis
All data were put into SPSS 10.0 statistical computer system. Statistical analysis was per‐
formed with t test or chi-square test, with statistical significance indicated by a value of
P≤0.05.
3. Results
The study included 55 cases, 45 cases of them were H.pylori (+). The neutrophilic infiltrate
was detected only in H.pylori (+) cases and the majority of cases were grade 3, 26 cases were
positive for lymphoplasmacytic infiltrate; 20 of them were H.pylori (+), 23 cases showing
atrophy; 20 of them were H.pylori (+) and the remaining 3 cases were H.pylori (-); they were
grade 1. Intestinal metaplasia were seen in 16 cases; 15 of them were H.pylori (+). Glandular
dysplasia was detected only in 10 cases; all of them were H.pylori (+). The degree of activity
of chronic gastritis was summarized in table (1).
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PNLs Lymphocytes Atrophy IM Dysplasia Sig.
n=38 n=26 n=23 N=16 n=10
0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
H.p
ylo
ri(-
)
N=
10
10
 (1
00
%) 0 0 0
4 (
40
%)
1 (
10
%)
2 (
20
%)
3 (
30
%)
7 (
70
%)
3 (
30
%) 0 0
9 (
90
%)
1 (
10
%) 0 0
10
 (1
00
%) 0 0 0 0.0
3
H.p
ylo
ri(+
)
N=
45
7 (
15
%)
10
 (2
2%
)
12
 (2
7%
)
16
 (3
6%
)
25
 (5
6%
)
10
 (2
2%
)
7 (
15
%)
3 (
7%
)
25
 (5
6%
)
11
 (2
4%
)
8 (
18
%)
1 (
2%
)
30
 (6
7%
)
7 (
15
%)
6 (
13
%)
2 (
5%
)
35
 (7
7%
)
3 (
7%
)
4 (
9%
)
3 (
7%
)
0.0
4
Sig 0.001 0.03 0.04 0.01 0.02
Table 1. The activity of chronic gastritis in the studied cases
Table (2) summarize the correlation study between the histological variables and the studied
oncogens. According to p53, the positive cases were 12 and all of them were H.pylori (+), 4 of
them were +, 5 were ++ and 3 were +++ as in figure (1). There were a significant difference be‐
tween the staining positivity of p53 and all the studied variables including neutrophilic infil‐
trate,  lymphoplasmacytic  infiltrate,  gastric  glandular  atrophy,  intestinal  metaplasia  and
dysplasia. According to c-Myc staining, the total positive cases were 10 and all of them were
H.pylori (+) cases, 4 were +, 3 were ++ as seen in figure (2) and 3 were +++. And again there were a
significant correlation between the staining positivity and the grades of the studied variables.
As the grade of chronic gastritis activity increases, the expression positivity of both p53 and c-
Myc increases, with significant difference between the grades as seen in table (2).
PNLs Lymphocytes Atrophy IM Dysplasia Total
0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
p5
3 (
n=
12
) -
7 (
16
%) 8 7 11 25 6 2 0 25 6 2 0 30 3 0 0 31 2 0 0 33
+ 0 2 2 0 0 3 1 0 0 2 2 0 0 1 3 0 4 0 0 0 4
++ 0 0 3 2 0 1 3 1 0 3 2 0 0 3 1 1 0 1 3 1 5
++
+ 0 0 0 3 0 0 1 2 0 0 2 1 0 0 2 1 0 0 1 2 3
Sig 0.003 0.02 0.01 0.02 0.004 55
c-M
yc 
(n=
10
) - 7 8 8 12 25 7 3 0 25 5 5 0 30 3 2 0 31 2 0 0 35
+ 0 2 2 0 0 2 2 0 0 4 0 0 0 2 2 0 2 0 2 0 4
++ 0 0 2 1 0 1 2 0 0 1 2 0 0 1 2 0 0 1 1 1 3
++
+ 0 0 0 3 0 0 0 3 0 1 1 1 0 0 1 2 0 0 1 2 3
Sig 0.01 0.009 0.03 0.005 0.03 55
Table 2. Correlation between the p53 and c-Myc and the studied histological variables in H.pylori (+) cases
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Figure 1. H.pylori (+) case showing +++ p53 expression, this case showed moderate intestinal metaplasia, note the
intense inflammatory infiltrate. (strept avidin-biotin-DAB, 400x).
Figure 2. c-Myc moderate expression in a case of H.pylori (+) case, the positivity mainly in intestinal metaplasia por‐
tion. (strept avidin-biotin-DAB, 200x).
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After treatment and complete resolution of H.pylori infection in all the cases, the same histo‐
pathological variables and immunohistochemical stainig of the studied oncogenes were
evalualed. The activity of chronic gastritis was measured and summarized in table (3). It
was found that the number of the cases which were positive for neutrophilic infiltrate, lym‐
phocytic infiltrtate, atrophy, intestinal metaplsia and even the glandular dysplasia were less
than the number before the treatment and even the grading of all these parameters become
much less as shown in table (3) when compared with table (1) with significant difference be‐
tween the same cases before and after treatment.
PNLs Lymphocytes Atrophy IM Dysplasia
n=18 n=8 n= 9 n=7 n=7
0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
Tre
ate
d c
ase
s
N=
45
27
 (6
0%
)
15
 (3
3%
)
3 (
7%
) 0
37
 (8
2%
)
4 (
9%
)
3 (
7%
)
1 (
2%
)
36
 (8
0%
)
5 (
11
%)
4 (
9%
) 0
38
 (8
4%
)
3 (
7%
)
3 (
7%
)
1 (
2%
)
38
 (8
4%
)
3 (
7%
)
2 (
4%
)
2 (
4%
)
Sig 0.004 0.003 0.005 0.009 0.007
Table 3. The activity of chronic gastritis in the studied cases after treatment:
As regarding p53 study after treatment, the number of positive cases become only 7 instead of
12, 3 cases were +, 3 cases were ++ as seen in figure (3) and only one case was +++. as regarding
the correlative study between p53 and the histological variables, there still positive correlation
between the p53 and all the variables of chronic gastritis as summarized in table (4).
PNLs Lymphocytes Atrophy IM Dysplasia Total
0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3 0 1 2 3
P5
3 (
n=
7) - 27 11 0 0 37 1 0 0 36 2 0 0 38 0 0 0 38 0 0 0 38
+ 0 3 0 0 0 2 1 0 0 2 1 0 0 2 2 0 0 2 1 0 3
++ 0 1 2 0 0 1 2 0 0 1 2 0 0 1 1 0 0 1 1 1 3
++
+ 0 0 1 0 0 0 0 1 0 0 1 0 0 0 0 1 0 0 0 1 1
Sig 0.01 0.01 0.03 0.02 0.01 45
c-M
yc(
n=
6) - 27 11 1 0 37 1 1 0 36 3 0 0 37 1 1 0 38 1 0 0 39
+ 0 2 1 0 0 3 0 0 0 2 1 0 1 1 1 0 0 2 1 0 3
++ 0 1 1 0 0 0 2 0 0 0 2 0 0 1 1 0 0 0 1 1 2
++
+ 0 1 0 0 0 0 0 1 0 0 1 0 0 0 0 1 0 0 0 1 1
Sig 0.03 0.04 0.04 0.02 0.01 45
Table 4. Correlation between p53 and c-Myc and the studied histological variables after treatment
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Figure 3. p53 expression after treatment in a case of chronic gastritis was +++ and become ++ confined to the area of
intestinal metasplasia (strept avidin-biotin-DAB, 400x).
Figure 4. c-Myc expression after treatment was ++ and become + expression only. (strept avidin-biotin-DAB, 400x).
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On the other hand, as regarding c-Myc study after treatment, the number of positive cases
become only 6 instead of 10, 3 cases were + as seen in figure (4), 2 cases were ++ and only
one case was +++. as regarding the correlative study between c-Myc positivity and the histo‐
logical variables, there still positive correlation between the c-Myc and all the variables of
chronic gastritis as summarized in table (4).
4. Discussion
In the present study, it was found that large number of chronic gastritis cases were associat‐
ed with H.pylori. In H.pylori (+) cases, the majority showed active neutrophilic infiltrate, lym‐
phocytic infiltrate with occasional lymphoid follicles, atrophy, intestinal metaplasia and
dysplasia.
c-Myc and p53 expression are the most widely used markers of genomic instability [10]. In‐
terestingly, in this work, c-Myc and p53 expression were not detected in H.pylori (-) cases
and this was similar to Van Der et al study [11].
In this work, with the lesions changed between the studied cases from active chronic gastri‐
tis to atrophic gastritis to intestinal metaplasia to dysplasia, the positive immunostaining
grades of p53 expression increased significantly, the increasing tendency for p53 had a good
linear correlation with lesions progression toword the more dangerous precancerous le‐
sions. It is indicated that increased p53 expression may be important molecular events in‐
volved in the early stage of gastric carcinogenesis. Thus, this accumulation may be useful
biomarkers to assess risk for the development of gastric carcinoma. This was similar to other
authors [1,4,12] who have reported that H.pylori-positive gastritis especially that accompa‐
nied with intestinal metaplasia showed a higher p53 expression. But unlike Anagnostopou‐
los et al [13] who reported that p53 was expressed only in cases with high grade dysplasia
and not in pre-dysplastic stages and concluded that p53 mutation is a late event during the
development of gastric cancer. Our results confirm the relationship between atrophic and/or
metaplastic gastric mucosa with H.pylori infection and p53 expression.
Marinone et al [14] data indicated that irreversible genetic changes in the p53 protein has not
yet occurred in non-neoplastic gastric mucosa with metaplasia and H.pylori related chronic
gastritis and they concluded that the increase in p53 levels is due to an increased production
of the wild-type protein probably related to an inflammatory response induced by H.pylori
infection.
In this work, H.pylori (-) cases were completely negative for c-Myc expression while H.pylori
infection was associated with positive expression of c-Myc unlike others [15] who found that
no evidence of expression of c-Myc in any gastritis sample. c-Myc has been reported to be
increased in H.pylori-associated gastritis, is associated with increased cell proliferation.
The results of this study may be explained by other studies [6,7] who found that in H.pylori-
associated gastritis, there is downregulation of p27 and increased c-Myc, the net result of
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which is increased cell proliferation and also H.pylori may influence both telomerase activity
and c-Myc expression in chronic atrophic gastritis.
Again in Zhan et al [16] study, expression of c-Myc was significantly higher in carcinoma
than that in dysplasia than in metaplasia. Also the expression of c-Myc in metaplastic cases
and dysplasia with H.pylori infection was significantly higher than that without infection; in
this work, c-Myc was completely negative in cases without H.pylori infection. So this study
support the others who concluded that H.pylori infection can cause serious imbalance be‐
tween cell proliferation and apoptosis in the precancerous lesions, giving chances for gastric
carcinogenesis.
After eradication treatment, it was found that there were decrease in the cases showed neu‐
trophilic and lymphocytic infiltration and even in the same case there was decrease in the
grade of the inflammatory infiltrate. Also the number and the grade of atrophy, intestinal
metaplasia and dysplasia were also significantly decreased.
The effects of H.pylori eradication on atrophy and intestinal metaplasia are controversial in
the previous studies. Some authors [17,18] have reported similar results with the present
work. The patchy nature of the lesions and the subjective nature of the interpretation may
account for these controversial findings. Our finding of disappearance or regression of atro‐
phy after H.pylori eradication suggests that inflammatory infiltration plays a role in this con‐
troversial histological finding. On the other hand, some studies [11] revealed no changes in
intestinal metaplasia and atrophy were detected after H.pylori eradication. While others [19]
reported that H.pylori eradication does not reduce the histologic metaplasia score, but
changes the cellular phenotype of metaplasia. This change of phenotype may be an impor‐
tant factor in the reduction of cancer incidence after eradication of H.pylori.
In the present study, H.pylori eradication led to a significant reduction in the expression of
p53. The number of p53-positive patients was significantly decreased and the grade of posi‐
tivity was also deceased significantly. Masaaki et al [1] also described a reduction in the ex‐
pression of p53 after eradication. They reported that H.pylori eradication reduced gastritis
activity, atrophy, and complete metaplasia, accompanied by the disappearance of genomic
instability markers.
After eradication therapy, the number of cases and the grade of positive c-Myc expression
was significantly deceased. This results was the same of others [7] who concuded that H.py‐
lori downregulates p27 and this is reversed following H.pylori eradication.
Finally we can conclude that, H.pylori infection in the gastric mucosa may be implicated in
the pathway of gastric carcinogenesis. it seems to be responsible for genomic instability and
its eradication can reverse inflammation and related atrophy, metaplasia, and genomic in‐
stability. So, we recommend that H.pylori patients especially those with precancerous lesions
should receive intense eradication therapy and closely monitored. Because this study con‐
firm that eradication reverses the atrophic changes in the gastric mucosa and the genetic in‐
stability, thus may prevent the development of gastric cancer
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